| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |